The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...

You can view the full lineup of EcoFlow’s Phase 2 Spring-to-Summer Sale here. For rest of the day, you can grab EcoFlow’s DELTA 2 Max 2,048Wh power station at $999 (Reg. $1,899) A sizeable ...

With a nickname, logos and everything that goes with a permanent brand identity now officially a part of who they are, the ...

Compass Pathways PLC (CMPS) advances in treatment-resistant depression trials while maintaining a robust financial position.

The FDA cleared the investigational new drug application of IDE849, a potential first-in-class DLL3-targeted antibody-drug ...

A potential $1 rally for Dogecoin sparks intrigue in the crypto market, while XRP and Mutuum Finance (MUTM) steal the spotlight with bolder predictions. Dogecoin’s 38% surge in May 2025 signals robust ...

"Tusks Up" will be the rallying cry for the Utah Mammoth -- the new name of the former Arizona Coyotes hockey team, which was ...

Venture Global's IPO was disastrous, with the stock price dropping from $25 to single digits due to customer arbitration ...

McAllen International Airport unveils a $100 million terminal expansion to accommodate surging passenger numbers and new ...

Their mission concept consists of a Human-Crewed Interplanetary Transport Architecture (HUCITAR) to explore Mars and Ceres (the largest body in the main asteroid belt) in a single journey.